Selvita S.A. Logo

Selvita S.A.

Preclinical CRO offering integrated drug discovery and development services.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW

Description

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 16:12
Korekta zawiadomienia
Polish 83.1 KB
2025-12-23 16:12
Korekta zawiadomienia
Polish 75.9 KB
2025-12-23 16:12
Zawiadomienie
Polish 77.3 KB
2025-12-23 16:12
Zawiadomienie
Polish 75.5 KB
2025-12-23 16:12
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie publicznej / Receipt…
Polish 1.8 KB
2025-12-18 21:44
Otrzymanie istotnego zlecenia / Receipt of a Significant Purchase Order - Conte…
English 2.0 KB
2025-12-18 21:44
Otrzymanie istotnego zlecenia / Receipt of a Significant Purchase Order - Conte…
Polish 1.5 KB
2025-11-27 19:13
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
English 2.4 KB
2025-11-27 19:13
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
Polish 2.0 KB
2025-11-25 17:41
Zawarcie umowy o dofinansowanie w ramach programu FENG / Conclusion of the co-f…
Polish 1.0 KB
2025-11-25 17:14
Powiadomienie 2
Polish 5.2 KB
2025-11-25 17:14
Powiadomienie 1
Polish 5.3 KB
2025-11-25 17:14
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 971 bytes
2025-11-21 17:19
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
Polish 1.1 KB
2025-11-21 17:01
19.1.MAR
Polish 4.4 KB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Selvita S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.